2/26/2010 - Translational Regenerative Medicine Event Features Venture Forum
ISTO Technologies, was recently selected to present at upcoming regenerative medicine event in Winston-Salem, NC.
Learn More...
2/16/2010 - ISTO Technologies Inc. to Present at the Canaccord Adams Musculoskeletal Conference
ISTO Technologies, Inc. announced today that it will participate in the 2010 Canaccord Adams Musculoskeletal Conference to be held at the Sheraton New Orleans Hotel on Tuesday, March 9, 2010.
Learn More...
4/28/2009 - ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
Learn More...
1/1/2009 - ISTO Technologies to present at OneMedPlace Emerging Company Finance Conference
St. Louis, MO - ISTO Technologies, Inc announced today that it will participate in the 2nd Annual OneMedPlace Emerging Company Finance Conference in San Francisco, CA from January 13-14, 2009
Learn More...
6/4/2008 - ISTO Technologies, Inc. To Present At 2nd Annua Jefferies & Company, Inc. Healthcare Conferencel
St. Louis, MO - ISTO Technologies, Inc., a privately held orthobiologic company, announced today that it will participate in the 2nd Annual Jefferies & Company, Inc. Healthcare Conference in New York, NY from June 24-26, 2008.
Learn More...
10/14/2008 - Frost & Sullivan Acknowledges ISTO Technologies’ Role in Developing Advanced Biologic Products for Bone Healing
Based on its recent analysis of the bone healing market, Frost & Sullivan recognizes ISTO Technologies, Inc. with the 2008 North American Frost & Sullivan Award for Product Innovation for its novel InQu® Bone Graft Extender and Substitute scaffold.
Learn More...
12/21/2007 - ISTO Technologies to present at OneMedPlace Finance Forum
Description
Learn More...
12/5/2007 - ISTO Technologies Announces New Chief Financial Officer
Description
Learn More...
11/13/2007 - ISTO Technologies, Inc. Appoints Blake Miles as Vice President of Sales
Description
Learn More...
10/24/2007 - ISTO Technologies introduces InQu™, a novel bone graft extender, at NASS, (North American Spine Society) convention.
Learn More...
10/1/2007 - ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by The United States Patent Office
Learn More...
9/24/2007 - ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Extender and Bone Graft Substitute
Learn More...
2/15/2007 - Zimmer Holdings and ISTO Technologies Announce Start of Neocartilage Clinical Trial
Learn More...
6/21/2006 - Zimmer Holdings and ISTO Technologies Announce IND Approval for Neocartilage Graft
Learn More...
8/31/2005 - ISTO Technologies Completes $10.8 Million Financing
Learn More...
5/17/2005 - ISTO Technologies’ Study Wins Best Abstract Award at the 2005 Annual Meeting for International Society for Cellular Therapy
Learn More...
9/4/2003 - Mitchell Seyedin, Ph.D., Joins ISTO Technologies, Inc. as President and Chief Executive Officer
Learn More...
1/17/2002 - Zimmer to collaborate with ISTO Technologies, Inc. to develop and commercialize potential breakthrough cartilage repair and regeneration technology
Learn More...
10/12/2001 - ISTO Technologies, Inc. receives $2 Million NIST award for Neocartilage Osteochondral allograft development
Learn More...